Editorial: Interval cancers: Learning from the past as we build for the future

American Journal of Gastroenterology

Volumn 108, Issue 8, 2013, Pages 1341-1343

  Dominitz, Jason A ^a   Robertson, Douglas J ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CHROMOENDOSCOPY; CLINICAL EFFECTIVENESS; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; HUMAN; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY; COLORECTAL TUMOR; FEMALE; MALE; MORTALITY; NOTE;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE;

EID: 84881168705     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.177     Document Type: Review

References (32)

1. Winawer SJ, Fletcher RH, Miller L et al. Colorectal cancer screening: clinical guidelines and rationale (see comments) (published errata appear in Gastroenterology 1997 Mar;112(3):1060 and 1998 Mar;114(3):625). Gastroenterology 1997;112:594-642.
2. Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Aff airs Cooperative Study Group 380. N Engl J Med 2000;343:162-8.
3. Imperiale TF, Wagner DR, Lin CY et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal fi ndings. N Engl J Med 2000;343:169-74.
4. Harewood GC, Lieberman DA. Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening. Clin Gastroenterol Hepatol 2004;2:72-7.
5. Vital signs: Colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep 2011;60:884-9.
6. Pignone M, Saha S, Hoerger T et al. Cost-eff ectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:96-104.
7. van Rijn JC, Reitsma JB, Stoker J et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101 : 343-50.
8. Pickhardt PJ, Nugent PA, Mysliwiec PA et al. Location of adenomas missed by optical colonoscopy. Ann Intern Med 2004;141:352-9.
9. Zauber AG, Winawer SJ, O ' Brien MJ et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96.
10. Baxter NN, Goldwasser MA, Paszat LF et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
11. Kahi CJ, Imperiale TF, Juliar BE et al. Eff ect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol 2009;7:770-5;quiz 711.
12. Cooper GS, Xu F, Barnholtz Sloan JS et al. Prevalence and predictors of interval colorectal cancers in medicare benefi ciaries. Cancer 2012;118 : 3044-52.
13. Singh H, Nugent Z, Demers AA et al. Rate and predictors of early/missed colorectal cancers aft er colonoscopy in Manitoba: a population-based study. Am J Gastroenterol 2010;105:2588-96.
14. de Wijkerslooth TR, Stoop EM, Bossuyt PM et al. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol 2012;107:1570-8.
15. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008;149:627-37.
16. Arain MA, Sawhney M, Sheikh S et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010;105:1189-95.
17. Pohl H, Robertson DJ. Colorectal cancers detected aft er colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol 2010;8:858-64.
18. Pohl H, Srivastava A, Bensen SP et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology 2013;144:74-80 e1.
19. Erichsen R, Baron JA, Stoff el EM et al. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study. Am J Gastroenterol 2013;108:1332-40 (this issue).
20. Bressler B, Paszat LF, Chen Z et al. Rates of new or missed colorectal cancers aft er colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007;132:96-102.
21. Baxter NN, Sutradhar R, Forbes SS et al. Analysis of administrative data fi nds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 2011;140:65-72.
22. Rex DK, Ahnen DJ, Baron JA et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315-29;quiz 1314, 1330.
23. Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795-803.
24. Coe SG, Crook JE, Diehl NN et al. An endoscopic quality improvement program improves detection of colorectal adenomas. Am J Gastroenterol 2013;108:219-26;quiz 227.
25. Brown SR, Baraza W. Chromoscopy versus conventional endoscopy for the detection of polyps in the colon and rectum. Cochrane Database Syst Rev 2010, CD006439.
26. Pasha SF, Leighton JA, Das A et al. Comparison of the yield and miss rate of narrow band imaging and white light endoscopy in patients undergoing screening or surveillance colonoscopy: a meta-analysis. Am J Gastroenterol 2012;107:363-70;quiz 371.
27. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only fl exible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
28. Jacob BJ, Sutradhar R, Moineddin R et al. Methodological approaches to population based research of screening procedures in the presence of selection bias and exposure measurement error: colonoscopy and colorectal cancer outcomes in Ontario. BMC Med Res Methodol 2013;13:59.
29. Sharaf RN, Ladabaum U. Comparative eff ectiveness and cost-eff ectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Am J Gastroenterol 2013;108:120-32.
30. Quintero E, Castells A, Bujanda L et al. Colonoscopy versus fecal immuno chemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
31. Kaminski MF, Bretthauer M, Zauber AG et al. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012;44:695-702.
32. Dominitz JA, Robertson DJ Colonoscopy versus fecal immunochemical test in reducing mortality from colorectal cancer (CONFIRM): http://clinicaltrialsgov/ ct2/show/NCT01239082.